These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38007068)
1. Dual-targeted nanoparticles with removing ROS inside and outside mitochondria for acute kidney injury treatment. Zhao M; Guo J; Tian C; Yan M; Zhou Y; Liu C; Pang M; Du B; Cheng G Nanomedicine; 2024 Jan; 55():102725. PubMed ID: 38007068 [TBL] [Abstract][Full Text] [Related]
2. Artesunate-Nanoliposome-TPP, a Novel Drug Delivery System That Targets the Mitochondria, Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Oxidative Stress and Inflammatory Effects. Zhang J; Gu L; Jiang Y; Ma Y; Zhang Z; Shen S; Shen S; Peng Q; Xiao W Int J Nanomedicine; 2024; 19():1385-1408. PubMed ID: 38371457 [TBL] [Abstract][Full Text] [Related]
3. Folic acid-targeted pluronic F127 micelles improve oxidative stress and inhibit fibrosis for increasing AKI efficacy. Du B; Zhao M; Wang Y; Yu L; Jiao Q; Bai Y; Cheng G Eur J Pharmacol; 2022 Sep; 930():175131. PubMed ID: 35872158 [TBL] [Abstract][Full Text] [Related]
4. Indispensable role of mitochondria in maintaining the therapeutic potential of curcumin in acute kidney injury. Li L; Liu S; Zhou Y; Zhao M; Wang Y; Wang C; Lou P; Huang R; Ma L; Lu Y; Fu P; Liu J J Cell Mol Med; 2021 Oct; 25(20):9863-9877. PubMed ID: 34532973 [TBL] [Abstract][Full Text] [Related]
5. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Yu H; Jin F; Liu D; Shu G; Wang X; Qi J; Sun M; Yang P; Jiang S; Ying X; Du Y Theranostics; 2020; 10(5):2342-2357. PubMed ID: 32104507 [TBL] [Abstract][Full Text] [Related]
6. Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway. Yang SK; Han YC; He JR; Yang M; Zhang W; Zhan M; Li AM; Li L; Na-Song ; Liu YT; Wu XQ; Zhang Q; Wang JW; Zhang H Biomed Pharmacother; 2020 Oct; 130():110521. PubMed ID: 32717631 [TBL] [Abstract][Full Text] [Related]
7. Role of curcumin in the treatment of acute kidney injury: research challenges and opportunities. Cai Y; Huang C; Zhou M; Xu S; Xie Y; Gao S; Yang Y; Deng Z; Zhang L; Shu J; Yan T; Wan CC Phytomedicine; 2022 Sep; 104():154306. PubMed ID: 35809376 [TBL] [Abstract][Full Text] [Related]
8. Umbelliferone attenuates cisplatin-induced acute kidney injury by inhibiting oxidative stress and inflammation via NRF2. Yang Z; Ning R; Liu Q; Zang R; Liu S; Sun S Physiol Rep; 2023 Dec; 11(23):e15879. PubMed ID: 38030388 [TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2. Yang Y; Liu S; Gao H; Wang P; Zhang Y; Zhang A; Jia Z; Huang S Free Radic Biol Med; 2020 May; 152():821-837. PubMed ID: 32004633 [TBL] [Abstract][Full Text] [Related]
10. Rapamycin attenuates mitochondrial injury and renal tubular cell apoptosis in experimental contrast-induced acute kidney injury in rats. Yang X; Yan X; Yang D; Zhou J; Song J; Yang D Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341250 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Targeted Antioxidant SKQ1 Ameliorates Acute Kidney Injury by Inhibiting Ferroptosis. Song J; Sheng J; Lei J; Gan W; Yang Y Oxid Med Cell Longev; 2022; 2022():2223957. PubMed ID: 36193064 [TBL] [Abstract][Full Text] [Related]
12. Dual-Responsive Curcumin-Loaded Nanoparticles for the Treatment of Cisplatin-Induced Acute Kidney Injury. Lan T; Guo H; Lu X; Geng K; Wu L; Luo Y; Zhu J; Shen X; Guo Q; Wu S Biomacromolecules; 2022 Dec; 23(12):5253-5266. PubMed ID: 36382792 [TBL] [Abstract][Full Text] [Related]
13. Sulfasalazine induces mitochondrial dysfunction and renal injury. Niknahad H; Heidari R; Mohammadzadeh R; Ommati MM; Khodaei F; Azarpira N; Abdoli N; Zarei M; Asadi B; Rasti M; Shirazi Yeganeh B; Taheri V; Saeedi A; Najibi A Ren Fail; 2017 Nov; 39(1):745-753. PubMed ID: 29214868 [TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury. Gong Q; Lai T; Liang L; Jiang Y; Liu F Mol Med; 2023 Oct; 29(1):140. PubMed ID: 37875838 [TBL] [Abstract][Full Text] [Related]
15. Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis. Xu Z; Zhang M; Wang W; Zhou S; Yu M; Qiu X; Jiang S; Wang X; Tang C; Li S; Wang CH; Zhu R; Peng WX; Zhao L; Fu X; Patzak A; Persson PB; Zhao L; Mao J; Shu Q; Lai EY; Zhang G Toxicol Appl Pharmacol; 2023 Aug; 473():116595. PubMed ID: 37328118 [TBL] [Abstract][Full Text] [Related]
16. Raw and salt-processed Achyranthes bidentata attenuate LPS-induced acute kidney injury by inhibiting ROS and apoptosis via an estrogen-like pathway. Wang S; Zeng M; Li B; Kan Y; Zhang B; Zheng X; Feng W Biomed Pharmacother; 2020 Sep; 129():110403. PubMed ID: 32574970 [TBL] [Abstract][Full Text] [Related]
17. Ethanol Extract of Islam MS; Miao L; Yu H; Han Z; Sun H Nutrients; 2019 Jun; 11(6):. PubMed ID: 31234591 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial targeted ROS scavenger based on nitroxide for treatment and MRI imaging of acute kidney injury. Tao Q; Zhang D; Zhang Q; Liu C; Ye S; Feng Y; Liu R Free Radic Res; 2022; 56(3-4):303-315. PubMed ID: 35746859 [TBL] [Abstract][Full Text] [Related]
19. Intervention of mitochondrial activity attenuates cisplatin-induced acute kidney injury. Yang Y; Fu Y; Wang P; Liu S; Sha Y; Zhang Y; Zhang A; Jia Z; Ding G; Huang S Int Urol Nephrol; 2019 Jul; 51(7):1207-1218. PubMed ID: 31020626 [TBL] [Abstract][Full Text] [Related]
20. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury. Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]